Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Fidia Spa ( (IT:FDA) ).
Fidia S.p.A. has reported that Global Growth Holding Limited has converted two bonds from the sixth tranche of its reserved convertible bond loan into 2,500,000 new shares at a price of €0.008 per share. The new shares have been issued to GGHL and admitted directly to trading on the regulated market, contributing to the ongoing execution of the company’s 2026 POC financing program.
Following this latest conversion, the POC has been subscribed for a nominal €1.5 million, with €1.45 million of the related capital increase already executed and five bonds from the sixth tranche still unconverted. As a result, Fidia’s share capital will rise by €20,000 to €11,297,761.90, and the total number of shares will increase to 105,709,593, modestly diluting existing shareholders while further strengthening the company’s equity base for its industrial and growth plans.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in high-performance integrated milling systems, numerical controls and CAM software for complex shapes. The group, with around 135 employees and over 50 years of experience, serves mainly the automotive mold sector and the aerospace industry, offering end-to-end solutions across the entire milling process.
Average Trading Volume: 3,026,755
Technical Sentiment Signal: Strong Sell
Current Market Cap: €598.8K
Find detailed analytics on FDA stock on TipRanks’ Stock Analysis page.